oncnursingnews7 小时
Nivolumab/Chemo Shows Lasting Benefit in Advanced Gastroesophageal Cancers
Five-year data shows lasting benefit for patients with advanced gastroesophageal cancers treated with nivolumab and chemotherapy.
oncnursingnews9 小时
Long-Term Survival Benefit Seen With Nivolumab Plus Chemo in Chinese Patients With Advanced ...
Nivolumab plus chemotherapy improved long-term survival in Chinese patients with advanced gastric, GEJ, or esophageal cancer.
oncnursingnews4 天
Ann Culkin, RN, OCN
Novel Drug Combo Is Promising for PD-L1-Resistant Solid Cancers ...
oncnursingnews4 天
Brenda Martone MSN, ANP-BC, AOCNP
Novel Drug Combo Is Promising for PD-L1-Resistant Solid Cancers ...
oncnursingnews4 天
Katie Goodman, RN, BSN, CCRP
Novel Drug Combo Is Promising for PD-L1-Resistant Solid Cancers ...
oncnursingnews5 天
Laurie Feingold, LSW
Novel Drug Combo Is Promising for PD-L1-Resistant Solid Cancers ...
oncnursingnews5 天
Cancer Prevention Foundation
Novel Drug Combo Is Promising for PD-L1-Resistant Solid Cancers ...
oncnursingnews5 天
Dorothy N. Pierce
Novel Drug Combo Is Promising for PD-L1-Resistant Solid Cancers ...
oncnursingnews6 天
Donna L. Berry, PhD, RN, AOCN, FAAN
Novel Drug Combo Is Promising for PD-L1-Resistant Solid Cancers ...
oncnursingnews6 天
Kate Sandstrom, MSN, APRN-BC, AOCN
Novel Drug Combo Is Promising for PD-L1-Resistant Solid Cancers ...
oncnursingnews6 天
Adding Lenvatinib/Pembrolizumab to TACE Extends PFS in Unresectable Liver Cancer
The addition of lenvatinib/pembrolizumab to TACE showed a numerical improvement in PFS, but longer follow-up is necessary to ...
oncnursingnews6 天
Investigational Nasal Spray May Improve Symptoms in Cancer Cachexia
Findings from an exploratory 2a study showed improvements in patients with cancer cachexia with PH284 compared with placebo.